Vaccines have been rigorously tested, reviewed, and monitored for decades. They are one of the greatest success stories in ...

The US Advisory Committee on Immunization Practices voted in June to stop recommending certain kinds of flu vaccines, a ...

Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

While the outlook for vaccines in the US looks bleak under Trump's administration, the UK is pressing ahead with securing its ...

The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has singled it out for scrutiny, clouding its prospects.

This is not the only norovirus vaccine currently in trials – for example, a trial of an mRNA vaccine was launched in the UK last year – but developers Vaxart believe there are a lot of ...

Another norovirus vaccine currently in development by Takeda Pharmaceuticals spinout HilleVax, using virus-like particles rather than mRNA, failed a phase II trial in infants in July after showing ...

New vaccine approved for over-60s - jab uses mRNA technology, just like the Covid shot READ MORE: New norovirus alert as officials warn of 'potential second wave' By EMILY STEARN, SENIOR HEALTH ...

Moderna posted a Q4 EPS loss of $(2.91), missing estimates, while revenue fell to $966M from $2.81B but beat the $942.8M consensus Moderna’s norovirus vaccine trial is on FDA hold due to a ...

One approach to a possible vaccine uses the same mRNA technology that was used in the creation of the Covid vaccines. This involves genetic information for the norovirus protein being injected ...